Molecular Level of Minimal Residual Disease in Bone Marrow Before High-Dose Therapy and Autologous Stem Cell Transplantation Is a Prognostic Parameter in Patients with Multiple Myeloma.
暂无分享，去创建一个
I. Bruns | G. Kobbe | R. Fenk | R. Haas | R. Kronenwett | A. Czibere | F. Neumann | Mark Korthals | A. Dienst | L. Ruf | F. Zohren | N. Sehnke | Nancy Safaian